Maseco LLP Viatris Inc Transaction History
Maseco LLP
- $2.63 Trillion
- Q2 2025
A detailed history of Maseco LLP transactions in Viatris Inc stock. As of the latest transaction made, Maseco LLP holds 20 shares of VTRS stock, worth $208. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20Holding current value
$208% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VTRS
# of Institutions
1,140Shares Held
973MCall Options Held
7.62MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA145MShares$1.51 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$966 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD78.8MShares$821 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az66.4MShares$692 Million3.26% of portfolio
-
State Street Corp Boston, MA55.3MShares$576 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $12.6B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...